Our top ten announcements and outputs from this year including 100 Tox Team papers published, 150 Project Grant Scheme awards and over £50M committed to replacement projects.
We are pleased to announce that Professor Cathy Abbott and Dr Andy Scott are joining the NC3Rs Board.
Announcing 24 projects through a joint call to develop the next generation of alternatives to in vivo models.
Over £1M awarded to exceptional 3Rs research and training projects
We have recently passed the milestone of awarding over £50M to replacement methods through our funding schemes.
Supporting the wider adoption of non-animal derived antibodies to realise scientific and animal welfare impacts.
An NC3Rs working group has published recommendations and guidance on best practice for high-yield rodent behavioural experiments.
We have recently committed over £2.8M to six new project grants supporting the development of new 3Rs approaches and technologies.
Funding of £1.2M is available through this year’s CRACK IT Challenges competition. The two Challenges encompass animal use in the key areas of endocrine disruption and CAR-T cell therapy.
Increased focused on replacement technologies as well as championing high standards in animal research.
An alternative technology making organ-on-a-chip systems more accessible to labs worldwide has won the 3Rs Prize, awarded by NC3Rs and co-funded by GSK.
We have now funded over 30 awards through the Skills and Knowledge Transfer scheme helping to facilitate the uptake of new 3Rs tools, models and technologies.
A total of £4M will be available to fund alternatives to in vivo models in bioscience research.
Supporting early career researchers with funding for disseminating their 3Rs research.
NC3Rs-funded research could replace mice in tropical disease research.
A new paper reports the top welfare indicators for laboratory macaques and marmosets and presents a protocol for welfare assessment of macaques.
A new paper demonstrates the positive welfare effects of rat playpens.
We recommend that all NC3Rs grant holders and stakeholders deposit their cells with The European Bank for induced pluripotent Stem Cells (EBiSC).
We have awarded over £0.5M to four talented 3Rs‑minded early career researchers to support their career development.
Learn more about this opportunity to have your research globally recognised.